Aging Populations And Precision Medicine Will Expand Oncology Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
11 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$10.00
68.9% undervalued intrinsic discount16 Aug
US$3.11
1Y
9.1%7D
5.8%